Presentations.AI, a Beautiful.ai Alternative, Launches Unlimited-Seat Team Plan to Challenge Per-User Pricing, Adding Automatic Brand Sync and Document-to-Presentation Conversion LBank Exchange Will List CyDotori Token (DOTR) on January 4, 2022
Internet City, Dubai–(Newsfile Corp. – December 31, 2021) – LBank Exchange, a global digital asset…
Gabelli Funds to Launch Third ETF – The Gabelli Asset ETF (GAST)
A Fund Focused on Beneficiaries of Automation GREENWICH, Conn.–(BUSINESS WIRE)–GAMCO Investors, Inc. (“GAMCO”) (NYSE: GBL)…
BitNile Holdings, through Its Subsidiary Ault Alliance, Acquires Property for $15.5 Million for Multifamily Project in Florida
LAS VEGAS–(BUSINESS WIRE)–$AGH #AmosKohn—BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or…
BitNile Holdings Obtains $52.2 Million in Secured Debt Financing
LAS VEGAS–(BUSINESS WIRE)–$AGH #AmosKohn—BitNile Holdings, Inc. (NYSE American: NILE), a diversified holding company (“BitNile” or…
Silver Tiger Provides 2021 Year-End Update
HALIFAX, NS / ACCESSWIRE / December 31, 2021 / Silver Tiger Metals Inc. (TSXV:SLVR)(OTCQX:SLVTF) (“Silver…
Empower Clinics Opens Its First “The Medi-Collective” in London, Ontario With Co-Located Guardian Pharmacy
The Clinic is Accepting New Patients as of Today and Doors Will Be Open January…
Board Member Leaves IRLAB for Another Assignment
GOTHENBURG, SE / ACCESSWIRE / December 31, 2021 / IRLAB Therapeutics (STO:IRLAB-A) (FRA:6IRA) IRLAB (Nasdaq…
MedMira Reports First Quarter Results FY2022
HALIFAX, Nova Scotia, Dec. 30, 2021 (GLOBE NEWSWIRE) — MedMira Inc. (MedMira) (TSXV: MIR), reported…
Mesoblast Provides Update Following Meeting With FDA’s OTAT on Remestemcel-L for Children With Acute Graft Versus Host Disease
Key Points: Meeting held with the US Food and Drug Administration’s (FDA) Office of Tissues…
Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults With Type 2 Diabetes
THE WOODLANDS, Texas, Dec. 30, 2021 (GLOBE NEWSWIRE) — Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today…
Akari Therapeutics, Plc Announces $6.0 Million Registered Direct Offering
NEW YORK and LONDON, Dec. 30, 2021 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX)…
Total number of shares and voting rights in Zealand Pharma at December 30, 2021
Company announcement – No. 78 / 2021 Total number of shares and voting rights in…
Ocugen Partner, Bharat Biotech, Announces Positive Immunogenicity and Safety Data From COVAXIN™ (BBV152), COVID-19 Candidate Vaccine, in Children 2 – 18 YEARS
COVAXIN™ whole virus inactivated vaccine generated broad antibody response comparable to those seen in a large…
Biofrontera Inc. announces reduction of Biofrontera AG shareholding to less than 50% through warrant exercises
WOBURN, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company…
Madrigal Provides Update on Timeline for Topline Results from the Phase 3 MAESTRO-NAFLD-1 Clinical Trial of Resmetirom
Company now expects to release topline 52-week results from MAESTRO-NAFLD-1 in January 2022 CONSHOHOCKEN, Pa.,…
BeyondSpring Announces Third Quarter 2021 Financial Results and Provides a Corporate Update
– Positive Phase 3 data in 2nd/3rd line NSCLC (Dublin-3): Superior efficacy benefit in plinabulin…
Lotus Ventures Inc. Reports Fiscal 2021 Results
VANCOUVER, British Columbia, Dec. 30, 2021 (GLOBE NEWSWIRE) — Lotus Ventures Inc. (CSE: J) (OTC:…
Repligen Corporation to Present at 40th Annual J.P. Morgan Healthcare Conference
WALTHAM, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) — Repligen Corporation (NASDAQ:RGEN), a life sciences company…
Registration Now Open For Tribe Public’s Webinar Event “Addressing The Increasing Demand For Rare Cannabinoids” Featuring InMed’s Management Team On January 6, 2022
Meet with InMed’s CEO Eric A. Adams, Shane Johnson, SVP and General Manager of BayMedica…
ProQR Announces Amendment to Convertible Debt Financing Agreement with Pontifax Ventures and Kreos Capital
LEIDEN, Netherlands & CAMBRIDGE, Mass., Dec. 30, 2021 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:PRQR) (“ProQR”),…